P/E ratio for Zimmer Biomet (ZBH)
P/E ratio as of April 2024 (TTM): 50.4
According to Zimmer Biomet's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 50.4232. At the end of 2022 the company had a P/E ratio of 116.
P/E ratio history for Zimmer Biomet from 2001 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | 116 | 81.37% |
| 2021 | 63.9 | -129.05% |
| 2020 | -220 | -934.17% |
| 2019 | 26.4 | -148.71% |
| 2018 | -54.1 | -520.52% |
| 2017 | 12.9 | -80.85% |
| 2016 | 67.2 | -38.56% |
| 2015 | 109 | 321.44% |
| 2014 | 26.0 | 28.88% |
| 2013 | 20.2 | 34.19% |
| 2012 | 15.0 | 16.97% |
| 2011 | 12.8 | -26.59% |
| 2010 | 17.5 | 1.48% |
| 2009 | 17.2 | 63.81% |
| 2008 | 10.5 | -46.27% |
| 2007 | 19.6 | -11.74% |
| 2006 | 22.2 | 0.3% |
| 2005 | 22.1 | -36.87% |
| 2004 | 35.0 | -14.9% |
| 2003 | 41.2 | 34.83% |
| 2002 | 30.5 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 Edwards Lifesciences EW | 37.3 | -25.95% | 🇺🇸 USA |
 Stryker Corporation SYK | 49.2 | -2.47% | 🇺🇸 USA |
 Cooper Companies COO | 16.5 | -67.36% | 🇺🇸 USA |
 Dentsply Sirona
XRAY | -30.9 | -161.20% | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.